# Comparison of clinical efficacy of unilateral biportal endoscopic lumbar interbody fusion and osterior lumbar interbody fusion in the treatment of L4/5 lumbar disc herniation

**Authors:** Kuoang Deng, Min Yang, Yongtao Xu

PMC · DOI: 10.3389/fsurg.2025.1719911 · Frontiers in Surgery · 2025-12-18

## TL;DR

This study compares two surgical methods for treating a specific type of back disc issue and finds that one method causes less blood loss and faster recovery, despite taking longer.

## Contribution

The study provides a direct comparison of clinical outcomes between ULIF and PLIF for L4/5 lumbar disc herniation.

## Key findings

- ULIF resulted in less blood loss, shorter hospital stay, and better early recovery compared to PLIF.
- ULIF showed lower levels of inflammation markers and improved pain and function scores postoperatively.
- ULIF required longer surgery time and more fluoroscopies compared to PLIF.

## Abstract

To compare the clinical efficacy between unilateral biportal endoscopic lumbar interbody fusion (ULIF) and traditional posterior lumbar interbody fusion (PLIF) in the treatment of L4/5 lumbar disc herniation (LDH).

A total of eighty-five patients with L4/5 LDH were enrolled and assigned into two groups: the ULIF group (n = 37) and the PLIF group (n = 48). Data regarding surgical conditions, hospital stay, perioperative Visual Analogue Scale (VAS) scores, Japanese Orthopaedic Association (JOA) scores, and serum inflammatory factor levels were recorded.

No statistically significant differences were observed in preoperative clinical characteristics (including age, disease duration, BMI, gender distribution, preoperative VAS scores, JOA scores, and serum inflammatory factor levels) between the two groups (all P > 0.05), indicating good comparability. Compared with the PLIF group, the ULIF group was associated with significantly less intraoperative blood loss, reduced postoperative drainage volume, and a shorter postoperative hospital stay (all P < 0.05). Additionally, the ULIF group exhibited lower serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP) at 24 h postoperatively, as well as significantly lower VAS scores and higher JOA scores at 7 and 30 days postoperatively (all P < 0.05). However, the ULIF group was associated with a longer operative time and a higher number of intraoperative C-arm fluoroscopies compared with the PLIF group (both P < 0.05).

ULIF exhibits significant advantages in minimally invasive. Although it requires longer operative time and more intraoperative fluoroscopies, it is associated with reduced blood loss, attenuated inflammatory responses, shorter hospital stay, and superior early postoperative pain and functional recovery, facilitating patient rehabilitation.

## Linked entities

- **Proteins:** IL6 (interleukin 6)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** postoperative pain (MESH:D010149), /5 (MESH:D008232), L4/5 LDH (MESH:C535531), inflammatory (MESH:D007249), blood loss (MESH:D016063)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12756358/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12756358/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12756358/full.md

---
Source: https://tomesphere.com/paper/PMC12756358